BioSpace News Archive

I-Mab today announced that the Company’s key shareholders including CBC Group (including its affiliates) and Hony Capital (collectively, the “Key Shareholders”) as well as its senior management team have voluntarily entered into a 180-days lock-up period commencing from March 31, 2022.

Select Medical Holdings Corporation, will release the financial results for its first quarter ended March 31, 2022 on Thursday, May 5, 2022 after the market closes.

ImmuneID today announced strategic partnerships with two world-class healthcare research organizations.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today the company will present research from its robust neurology portfolio, including the findings on lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody being developed for the treatment of early Alzheimer’s disease (AD) at the American Academy.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from two Phase 2 proof-of-concept (POC) studies that investigated treatment with the selective NaV1.8 inhibitor VX-548 for acute pain following abdominoplasty surgery or bunionectomy surgery.

Biognosys announced today the details of its presence at the American Association for Cancer Research (AACR) Annual Meeting 2022, which will be held April 8-13, 2022.

Gnubiotics Sciences SA today announced a poster presentation on the use of Glycopeptides to promote anti-cancer immune response against solid tumors at the American Association for Cancer Research (AACR) Annual Meeting 2022, scheduled for April 8-13, 2022 in New Orleans, Louisiana (USA).

Madison Core Laboratories, LLC (MCL) announces the appointment of Jeff Wisotzkey, Ph.D., HCLD, CC, as Chief Scientific Officer and Laboratory Director.

Materna Medical announced the completion of the activation of the fifteenth U.S. clinical study site participating in the pivotal EASE trial.

Vivos Therapeutics, Inc today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2021.